Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Debt / NOTE 0.750%10/1
-
Market price (% of par)
-
113.35%
-
Total 13F principal
-
$340,484,200
-
Principal change
-
-$6,955,000
-
Total reported market value
-
$386,409,638
-
Number of holders
-
41
-
Value change
-
-$7,779,379
-
Number of buys
-
13
-
Number of sells
-
19
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 as of Q1 2017
As of 31 Mar 2017,
BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 was held by
41 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$340,484,200
in principal (par value) of the bond.
The largest 10 bondholders included
ADVENT CAPITAL MANAGEMENT /DE/, Allianz Asset Management GmbH, Calamos Advisors LLC, MACKAY SHIELDS LLC, OAKTREE CAPITAL MANAGEMENT LP, Partner Fund Management, L.P., JPMORGAN CHASE & CO, BAKER BROS. ADVISORS LP, CREDIT SUISSE AG/, and Invesco Ltd..
This page lists
41
institutional bondholders reporting positions
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.